How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Single-use Chromatography Systems for Medical Market
- By Chromatography Technique: Affinity Chromatography, Ion Exchange Chromatography, Hydrophobic Interaction Chromatography, Size Exclusion Chromatography, Mixed-Mode Chromatography
- By Application: Monoclonal Antibody Purification, Viral Vector Purification, Recombinant Protein Purification, Vaccine Purification, Gene Therapy Product Purification
- By End User: Biopharmaceutical Manufacturers, Contract Development and Manufacturing Organizations (CDMOs), Academic and Research Institutions, Clinical Research Organizations (CROs), Biotechnology Companies
- By System Configuration: Pre-packed Single-use Columns, Single-use Membrane Adsorbers, Single-use Chromatography Skids, Disposable Chromatography Cartridges
- By Scale of Operation: Laboratory Scale, Pilot Scale, Commercial Scale
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Affinity Chromatography leads By Chromatography Technique at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 12 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 291 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.181 →
- 12 Company Profiles 12 players: SWOT & benchmarking p.189 →
Full report · locked preview
Everything inside the Single-use Chromatography Systems for Medical Market report
A complete, evidence-based study - 12 chapters and 122 sections covering market size, segmentation across 5 axes, regional analysis and 12 company profiles, forecast to 2033.
Segmentation covered
Chromatography Technique 5
Application 5
End User 5
System Configuration 4
Scale of Operation 3
Companies profiled
Cytiva (a Danaher company)
Sartorius AG
GE Healthcare Life Sciences (now part of Cytiva)
Merck KGaA (MilliporeSigma in the US and Canada)
Thermo Fisher Scientific
Repligen Corporation
Pall Corporation (a Danaher company)
Tosoh Corporation
Bio-Rad Laboratories
Agilent Technologies
Eppendorf AG
Semba Biosciences
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
12 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Cytiva (a Danaher company)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Sartorius AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →GE Healthcare Life Sciences (now part of Cytiva)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Merck KGaA (MilliporeSigma in the US and Canada)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Thermo Fisher Scientific
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Repligen Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →Pall Corporation (a Danaher company)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Tosoh Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Bio-Rad Laboratories
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Agilent Technologies
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.209 →Eppendorf AG
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.214 →Semba Biosciences
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.220 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$10,768M by 2033 · 11.4% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Affinity Chromatography52.4
- Ion Exchange Chromatography10.1
- Hydrophobic Interaction Chromatography19.4
- Size Exclusion Chromatography8.0
- Mixed-Mode Chromatography10.2
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$1,498M → $3,741M · 12.1%
Europe$1,044M → $2,271M · 10.2%
Asia Pacific$953.5M → $2,316M · 11.7%
Latin America$590.3M → $1,301M · 10.4%
Middle East and Africa$454.1M → $1,076M · 11.4%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →11.362026
11.352027
11.372028
11.392029
11.402030
11.402031
11.422032
11.432033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Cytiva (a Danaher company)22.4
- Sartorius AG16.8
- GE Healthcare Life Sciences (now part of Cytiva)11.3
- Merck KGaA (MilliporeSigma in the US and Canada)3.7
- Thermo Fisher Scientific11.6
- Repligen Corporation6.0
- Others28.2
Segment contribution to growth (%)
Fig. 18 · p.39 →Chromatography Technique11.4%
Application17.6%
End User17.7%
System Configuration26.9%
Scale of Operation26.4%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America34.9
- Europe21.2
- Asia Pacific21.6
- Latin America12.2
- Middle East and Africa10.1
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Cytiva (a Danaher company) | 90 | 85 | 78 | 74 | 74 | 96 | 83 |
| Sartorius AG | 72 | 92 | 92 | 70 | 84 | 85 | 83 |
| GE Healthcare Life Sciences (now part of Cytiva) | 76 | 74 | 69 | 68 | 64 | 80 | 72 |
| Merck KGaA (MilliporeSigma in the US and Canada) | 68 | 69 | 71 | 64 | 63 | 78 | 69 |
| Thermo Fisher Scientific | 71 | 58 | 52 | 59 | 76 | 76 | 65 |
| Repligen Corporation | 52 | 52 | 47 | 59 | 55 | 49 | 52 |
| Pall Corporation (a Danaher company) | 41 | 61 | 61 | 66 | 57 | 49 | 56 |
| Tosoh Corporation | 35 | 35 | 59 | 55 | 49 | 47 | 47 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Cytiva (a Danaher company)
- Sartorius AG
- GE Healthcare Life Sciences (now part of Cytiva)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Cytiva (a Danaher company) | ✓ | ✓ | ◐ | ◐ | − | ◐ |
| Sartorius AG | − | ✓ | ✓ | ◐ | ✓ | ✓ |
| GE Healthcare Life Sciences (now part of Cytiva) | ◐ | ◐ | − | − | ✓ | ◐ |
| Merck KGaA (MilliporeSigma in the US and Canada) | ◐ | ✓ | ✓ | − | − | ◐ |
| Thermo Fisher Scientific | − | ◐ | − | − | ✓ | ✓ |
| Repligen Corporation | − | − | − | ◐ | ◐ | − |
| Pall Corporation (a Danaher company) | − | ◐ | ◐ | ◐ | − | − |
| Tosoh Corporation | − | − | ◐ | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Cytiva (a Danaher company)83
2Sartorius AG83
3GE Healthcare Life Sciences (now part of Cytiva)72
4Merck KGaA (MilliporeSigma in the US and Canada)69
5Thermo Fisher Scientific65
6Pall Corporation (a Danaher company)56
7Repligen Corporation52
8Tosoh Corporation47
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Cytiva (a Danaher company)Sartorius AG
Challenger2
Strong scale, closing on the leaders.
GE Healthcare Life Sciences (now part of Cytiva)Merck KGaA (MilliporeSigma in the US and Canada)
Contender1
Focused players with pockets of strength.
Thermo Fisher Scientific
Niche3
Specialists in a single segment or region.
Repligen CorporationPall Corporation (a Danaher company)Tosoh Corporation
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Chromatography Technique in North America, then scale across Single-use Chromatography Systems for Medical Market — a $253M beachhead inside a $3.90B market.
Beachhead (SOM)$253Mobtainable near-term
Serviceable (SAM)$1.46Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale5 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion92 fit
Affinity Chromatography
Best fit — highest urgency & budget in Chromatography Technique.
Economic buyer76 fit
Ion Exchange Chromatography
Strong fit — clear ROI and a fast path to value.
End user68 fit
Hydrophobic Interaction Chromatography
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Chromatography Technique in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Application & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + End User
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales42%
Partner / channel28%
Digital / self-serve22%
Marketplaces9%
Positioning & messaging
§GTM 2 · p.194 →For Chromatography Technique leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Single-use Chromatography Systems for Medical Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified46%
Sales qualified23%
Evaluation12%
Closed-won8%
$19.9KCAC
$87KLTV
4.4:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Single-use Chromatography Systems for Medical Market is a durable-growth opportunity — $4.18B by 2033, compounding at 8.8%.
TAM · 2025$2.13Btoday
TAM · 2033$4.18Bforecast
CAGR8.8%2027–2033
Cumulative$27.5Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$4.18BTotal addressable market
SAM$1.47BServiceable available market
SOM$306MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →8.8% CAGR
Demand compounds through 2033, outpacing GDP across Chromatography Technique.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Chromatography Technique moving from early to mainstream — durable secular demand.
Consolidation upside
12+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$4.18BLarge & growingTAM by 2033 at 8.8% CAGR
$1.47BServiceable nowreachable with today’s model
$306MBeachhead winobtainable near-term share
12+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$3.26BBear5.7% CAGR
$4.18BBase8.8% CAGR
$5.35BBull11.6% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Application optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Single-use Chromatography Systems for Medical Market — a $3.67B market by 2033. Plan: grow share from 9.2% to 18.9%.
Market size · 2033$3.67Btotal addressable
Market CAGR8.1%2027–2033
Target share18.9%from 9.2% today
Revenue ambition$694Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 9.2% | 18.9% | Behind |
| Revenue | $337M | $694M | At risk |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Behind |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | On track |
| Gross margin | 30.0% | 44.4% | Behind |
| Customer retention | 90.9% | 93.0% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Chromatography Technique
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Application capability
A defensible second engine — invest in Application to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Chromatography Technique share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Application
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $71M capacity & capability investment
- Greenlight bolt-on M&A in Application
- Authorise North America expansion plan
- Fund R&D program for Chromatography Technique leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskOn track
- Regulatory / policy changeAhead
- Execution & talentAt risk
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Single-use Chromatography Systems for Medical Market conversation — a $7.30B market you can size, segment and defend in minutes.
Market size · 2033$7.30Btotal opportunity
Growth4.5%CAGR to 2033
Addressable buyers1,383+accounts in scope
Typical ROI7.4×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Chromatography Technique
Goal Grow share in Chromatography Technique
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →7.4×return on cost, year one
< 2 mopayback period
$96K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
12+players profiled in this market
Coverage includes
Cytiva (a Danaher company)Sartorius AGGE Healthcare Life Sciences (now part of Cytiva)Merck KGaA (MilliporeSigma in the US and Canada)Thermo Fisher ScientificRepligen CorporationPall Corporation (a Danaher company)Tosoh Corporation+4 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Single-use Chromatography Systems for Medical Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Single-use Chromatography Systems for Medical Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Single-Use Chromatography Market
Market size, share, segmentation and regional forecast.
$995M market · 2025 base year
View reportSingle Use Cervical Dilator Canal Dilators Market
Market size, share, segmentation and regional forecast.
$3.4B market · 2025 base year
View reportSingle Use Centrifuge Systems Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportSingle-Use Centrifuge Machines Market
Market size, share, segmentation and regional forecast.
$2.4B market · 2025 base year
View reportSingle Use Cell Culture Bags Market
Market size, share, segmentation and regional forecast.
$4.9B market · 2025 base year
View reportSingle-Use Cardiac Fixator Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportSingle Use Cannula Trocar Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportSingle Use Bronchoscopes Market
Market size, share, segmentation and regional forecast.
$5.8B market · 2025 base year
View reportSingle-use Bronchoscope Market
Market size, share, segmentation and regional forecast.
$691M market · 2025 base year
View reportSingle-Use Blood Oxygen Probe Market
Market size, share, segmentation and regional forecast.
$3.6B market · 2025 base year
View reportSingle-use Bioreactor Systems Market
Market size, share, segmentation and regional forecast.
$899M market · 2025 base year
View reportSingle-use Bioprocessors Sensors Market
Market size, share, segmentation and regional forecast.
$950M market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.